doi:10.1001/archneur.1992.00530350051019 Ando S, Tadenuma T, Tanaka Y, et al
Loren Pickart isolated the tripeptide glycyl-L-histidyl-L-lysine (GHK) from human plasma
The formulation is crafted with purity and sustainability in mind, being gluten-free, keto-friendly, and sugar-free, with minimal additives to ensure maximum health benefits
Improved hydration retention : Enhanced moisture-binding leads to visibly plumper, less crepey skin, especially in dehydrated or mature complexions
Elevate IGF-1 Higher liver-derived IGF-1 drives lipolysis, collagen synthesis, and lean-muscle accrual
Last month (May 2025), Novo Nordisk and Septerna, a San Francisco, California-based bio/pharmaceutical company focused on GCPRs, formed an exclusive global collaboration and license agreement to discover, develop, and commercialize oral small-molecule medicines for treating obesity, Type 2 diabetes, and other cardiometabolic diseases, in a deal worth up to $2.2 billion ($200 million upfront and near-term funding and $2 billion in milestone payments)